B
102.95
0.00 (0.00%)
| Penutupan Terdahulu | 102.95 |
| Buka | 102.99 |
| Jumlah Dagangan | 5,737,584 |
| Purata Dagangan (3B) | 8,544,491 |
| Modal Pasaran | 152,309,366,784 |
| Harga / Pendapatan (P/E TTM) | 75.15 |
| Harga / Pendapatan (P/E Ke hadapan) | 34.84 |
| Harga / Jualan (P/S) | 8.61 |
| Harga / Buku (P/B) | 6.76 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 22 Jul 2025 - 28 Jul 2025 |
| Margin Keuntungan | 11.58% |
| Margin Operasi (TTM) | 20.09% |
| EPS Cair (TTM) | 1.37 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 20.90% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 36.20% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 52.16% |
| Nisbah Semasa (MRQ) | 1.45 |
| Aliran Tunai Operasi (OCF TTM) | 3.81 B |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 2.32 B |
| Pulangan Atas Aset (ROA TTM) | 5.28% |
| Pulangan Atas Ekuiti (ROE TTM) | 9.50% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Menurun | Bercampur |
| Medical Devices (Global) | Menurun | Bercampur | |
| Stok | Boston Scientific Corporation | Bercampur | Menaik |
AISkor Stockmoo
-0.4
| Konsensus Penganalisis | 2.0 |
| Aktiviti Orang Dalam | -3.0 |
| Volatiliti Harga | -0.5 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -0.5 |
| Purata | -0.40 |
|
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Large Core |
| % Dimiliki oleh Orang Dalam | 0.18% |
| % Dimiliki oleh Institusi | 93.25% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Bollard Group Llc | 31 Dec 2024 | 20,733,226 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 125.00 (Citigroup, 21.42%) | Beli |
| 125.00 (Morgan Stanley, 21.42%) | Beli | |
| 125.00 (Barclays, 21.42%) | Beli | |
| Median | 120.00 (16.56%) | |
| Rendah | 112.00 (Evercore ISI Group, 8.79%) | Beli |
| Purata | 119.67 (16.24%) | |
| Jumlah | 9 Beli | |
| Harga Purata @ Panggilan | 102.56 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Leerink Partners | 16 Jun 2025 | 118.00 (14.62%) | Beli | 101.49 |
| Needham | 28 May 2025 | 115.00 (11.70%) | Beli | 104.51 |
| 24 Apr 2025 | 115.00 (11.70%) | Beli | 101.14 | |
| Citigroup | 22 May 2025 | 125.00 (21.42%) | Beli | 104.50 |
| Morgan Stanley | 16 May 2025 | 125.00 (21.42%) | Beli | 106.04 |
| Barclays | 25 Apr 2025 | 125.00 (21.42%) | Beli | 101.90 |
| Baird | 24 Apr 2025 | 120.00 (16.56%) | Beli | 101.14 |
| Evercore ISI Group | 24 Apr 2025 | 112.00 (8.79%) | Beli | 101.14 |
| RBC Capital | 24 Apr 2025 | 120.00 (16.56%) | Beli | 101.14 |
| Truist Securities | 24 Apr 2025 | 117.00 (13.65%) | Beli | 101.14 |
| 11 Apr 2025 | 113.00 (9.76%) | Beli | 93.67 | |
| Papar semua | ||||
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| FITZGERALD JOSEPH MICHAEL | - | 102.43 | -56,372 | -5,774,184 |
| Jumlah Keseluruhan Kuantiti Bersih | -56,372 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -5,774,184 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 102.43 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| FITZGERALD JOSEPH MICHAEL | Pegawai | 04 Jun 2025 | Jual automatik (-) | 56,372 | 102.43 | 5,774,184 |
| FITZGERALD JOSEPH MICHAEL | Pegawai | 04 Jun 2025 | Pelaksanaan pilihan | 56,372 | - | - |
| Tarikh | Jenis | Butiran |
|---|---|---|
| 01 May 2025 | Pengumuman | Boston Scientific announces upcoming investor conference schedule |
| 24 Apr 2025 | Pengumuman | Second phase of ADVANTAGE AF study of FARAPULSE™ Pulsed Field Ablation System meets primary safety and efficacy endpoints |
| 23 Apr 2025 | Pengumuman | Boston Scientific Chief Financial Officer (CFO) Dan Brennan to retire; Jon Monson, senior vice president, Investor Relations to succeed Brennan |
| 23 Apr 2025 | Pengumuman | Boston Scientific announces results for first quarter 2025 |
| 01 Apr 2025 | Pengumuman | Boston Scientific announces conference call discussing first quarter 2025 results |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |